Chronic Kidney Disease Progression Slowing Protocol
Chronic Kidney Disease Progression Slowing Protocol framework focused on consistent execution, practical monitoring, and safer progression.
An adjunctive protocol for individuals with CKD stages 2–4 targeting the mitochondrial dysfunction, inflammatory nephropathy, and oxidative damage that drive progressive kidney function decline.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Chronic Kidney Disease Progression Slowing Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
Ongoing with quarterly kidney function monitoring (eGFR, creatinine, urine protein); always adjunct to nephrology care
Target Audience
CKD stage 2–4 patients seeking to slow progression; post-AKI patients at high risk for CKD development
| Compound | Dose | Frequency |
|---|---|---|
| ARA-290 Nephroprotective; reduces tubular apoptosis and inflammatory infiltration in CKD | 4 mcg/kg | 3x/week |
| SS-31 (Elamipretide) Renal mitochondrial cardiolipin protection; restores tubular ATP production in CKD | 4 mg/kg | Daily |
| BPC-157 Renal vascular protection and anti-fibrotic effects; reduces progressive glomerulosclerosis | 250 mcg | Twice daily |
| NAD+ NAD+ repletion is critical in CKD; reduces tubular inflammation via SIRT1/SIRT3 activation | 500 mg (NMN equivalent) | Daily |
| Thymosin Alpha-1 Modulates T-cell-mediated inflammatory nephropathy; reduces immune-driven GFR decline | 1.6 mg | 3x/week |
| VIP Renal anti-inflammatory; reduces TNF-α and IL-6 in inflammatory nephropathy | 25 nmol | Daily |
Free Peptide Guide
Chronic Kidney Disease Progression Slowing Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned ARA-290 timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Chronic Kidney Disease Progression Slowing Protocol run before reassessment?
A common window is Ongoing with quarterly kidney function monitoring (eGFR, creatinine, urine protein); always adjunct to nephrology care, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with ARA-290 + SS-31 (Elamipretide) execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
CKD progression is driven by sustained mitochondrial dysfunction in renal tubular cells, glomerular inflammation, oxidative stress, and maladaptive fibrosis. ARA-290 has shown direct nephroprotective effects in multiple CKD models, reducing tubular apoptosis and inflammatory infiltration through innate repair receptor activation. SS-31 (Elamipretide) specifically targets cardiolipin in renal mitochondria, restoring ATP production and reducing tubular cell death in AKI and CKD models. BPC-157 protects the renal vasculature and reduces fibrosis through VEGF and growth factor modulation. NAD+ is critically depleted in CKD and its repletion reduces tubular inflammation and preserves glomerular filtration. Thymosin Alpha-1 modulates the T-cell-mediated inflammatory nephropathy. VIP reduces renal inflammatory cytokine production.
Clinical Research
No clinical references were provided for this stack yet.
More General Wellness Stacks
Altitude & Mountaineering Performance Protocol
A protocol for mountaineers, altitude athletes, and competitive cyclists targeting improved hypoxic adaptation, pulmonary vasodilation to prevent HAPE, enhanced oxygen utilization efficiency, and accelerated recovery from altitude-induced tissue stress.
COPD & Pulmonary Rehabilitation Protocol
An adjunctive protocol for individuals with COPD and other chronic lung diseases targeting the airway inflammation, pulmonary fibrosis, mucociliary dysfunction, and systemic muscle wasting that drive progressive respiratory decline.
Chronic Kidney Disease (CKD) Support Protocol
A nephroprotective protocol for patients with CKD stages 2–4, addressing progressive renal inflammation, anemia, muscle wasting (sarcopenia), peripheral neuropathy, and immune suppression through carefully selected peptides with renal safety profiles.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Chronic Kidney Disease Progression Slowing Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.